Are SARMs safer than anabolic steroids?

SARMs are designed to be tissue-selective, meaning they target androgen receptors in muscle and bone while showing less androgenic activity in the prostate, skin, and hair. However, they are still investigational compounds with incomplete clinical profiles. While they avoid aromatization to estrogen and some 17α-alkylation issues, they still carry risks of suppression, liver enzyme elevation, and lipid profile changes.

Do SARMs shut down natural testosterone production?

Yes. A common misconception is that SARMs do not cause suppression. While mild SARMs (like Ostarine at low doses) may only cause moderate suppression, stronger compounds (like RAD-140 or LGD-4033) can severely suppress the HPTA. A proper post-cycle therapy (PCT) is strongly recommended after any SARM cycle.

Do SARMs require liver protection like oral steroids?

Yes. Although SARMs are not 17α-alkylated in the same manner as oral anabolic steroids (like Dianabol or Superdrol), clinical data and user bloodwork show they can still cause reversible liver enzyme (ALT/AST) elevations. Using mild liver support such as NAC (N-acetyl cysteine) or TUDCA is a sensible precaution.

SARMs vs anabolic steroids: a transparent comparison

Updated 2026-05-19 · Reviewed by the DeusPowershop editorial team

Selective Androgen Receptor Modulators (SARMs) and traditional anabolic-androgenic steroids (AAS) represent two different generations of performance-enhancing compounds. While both bind to the androgen receptor to stimulate muscle growth and bone density, they differ fundamentally in their tissue selectivity, side-effect profiles, and chemical classification. For comprehensive scientific background, see the Wikipedia page on SARMs and the clinical review of androgen receptor targeting (PMC2907129). Examine.com SARMs overview.

Understanding the mechanism: Selectivity vs Global Action

The primary distinction between the two drug classes lies in how they interact with cellular receptors:

Anabolic Steroids (AAS): These are synthetic derivatives of testosterone. When introduced, they bind globally to androgen receptors across all tissues in the body. This triggers muscle protein synthesis, but also prompts androgenic changes in secondary organs, leading to side effects like prostate enlargement, acne, and accelerated hair loss.
SARMs: These are non-steroidal molecules specifically designed to be tissue-selective. They are engineered to act as full agonists in skeletal muscle and bone, while acting as partial agonists or antagonists in other tissues like the prostate and sebaceous glands. This selectivity is measured by their high anabolic-to-androgenic ratio.

Comparative Overview of Key Parameters

Below is a transparent comparison highlighting how these compounds stack up across core clinical markers:

Parameter	SARMs (e.g. RAD-140, LGD-4033)	Anabolic Steroids (e.g. Testosterone, Dianabol)
Chemical Class	Non-steroidal ligands	Steroidal structures (androstane derivatives)
Selectivity	High (targeted to skeletal muscle & bone)	Low (systemic activity across all tissues)
Estrogenic Effects	None (do not aromatize or bind estrogen receptors)	Variable (many aromatize, causing water retention/gynecomastia)
HPTA Suppression	Dose-dependent (mild to moderate-severe)	Severe/Complete (typically shuts down HPTA entirely)
Hepatotoxicity	Low-to-moderate (reversible enzyme elevations)	High for oral 17α-alkyl compounds; low for injectables
Administration	Orally (liquids, capsules)	Mainly injectable (oils, suspensions); some oral options

The post-cycle therapy (PCT) requirement

A critical mistake made by beginners is assuming SARMs do not require post-cycle therapy. Because SARMs bind tightly to the androgen receptor, they still provide negative feedback to the pituitary gland. This results in a down-regulation of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH), depressing natural testosterone output.

While a mild Ostarine (MK-2866) run might only require a light recovery phase, stronger compounds such as Testolone (RAD-140) or Ligandrol (LGD-4033) can depress testosterone levels by up to 70%. Consequently, a standard post-cycle recovery protocol using SERMs (like Clomid or Nolvadex) is crucial to re-establish normal endocrine function. Read our detailed Post-Cycle Therapy (PCT) guide for structured dosing templates.

Liver stress and cholesterol impact

Although SARMs are non-steroidal and lack the classic 17α-alkylation chemical signature of oral steroids like Dianabol or Winstrol, they are still metabolized primarily by the liver. Multi-center clinical trials have shown that even moderate doses of SARMs can trigger elevated ALT and AST enzymes.

Furthermore, both classes significantly suppress High-Density Lipoprotein (HDL) cholesterol while occasionally raising Low-Density Lipoprotein (LDL), altering cardiovascular risk markers. To mitigate liver stress, on-cycle support with antioxidants like NAC (600–1200 mg/day) or on-cycle liver support is strongly advised. Read our guide on TUDCA cycle support for deep details on protecting liver tissue during cycles.

Where to go next

Browse the peptides & selective modulators catalog to learn about available options.
Explore oral testosterone alternatives in the oral steroids catalog.
Read Beginner peptide stack: how to start for injury repair protocols.